Basking Biosciences
2 known investors
Basking Biosciences develops therapeutics for thrombosis, vascular biology, and ischemic disease. The company focuses on stroke and cardiovascular applications.
BiotechDigital HealthHealthtechMedical Devices
Founders & leadership
SN
Shahid NimjeeCo-founder, Chief Scientific Officer and Stroke Clinical Lead
BS
Bruce SullengerCo-founder
Investors · 2
In the news
- Basking Biosciences | Investment | Insight Partnersinsightpartners.com · 2026
- Basking Biosciences Doses First Patients in Part B of Phase 2 Stroke Trial, Unlocks $27.5 Million Financing Tranche, and Appoints Julia C. Owens, Ph.D. as Chief Executive Officerprnewswire.com · 2025
- Ohio State spinoff Basking Biosciences raises $55 million to test stroke treatmentohiotechnews.com · 2024
- Fast-acting reversible stroke treatment developer Basking Biosciences raises $55M - Columbus Business Firstbizjournals.com · 2024
- Basking Biosciences Closes $55M Financingfinsmes.com · 2024
- Triangle-based Basking Biosciences raises $27.5 million - Business North Carolinabusinessnc.com · 2023